Faculty

	Ike K. Ahmed, MD, FRCSC (Chair) Professor University of Utah Salt Lake City, Utah Assistant Professor Director, Glaucoma and Advanced Anterior Segment Surgery (GAASS) Fellowship Research Director, Kensington Eye Institute University of Toronto Toronto, Canada Division Head, Division of Ophthalmology Trillium Health Partners Co-Medical Director, TLC Mississauga, Canada Medical Director, Prism Eye Institute Mississauga and Brampton, Canada
	Sahar Bedrood, MD, PhD Ophthalmologist Acuity Eye Group Adjunct Clinical Assistant Professor USC Roski Eye Institute Los Angeles County + USC Medical Center Pasadena, California
	Brian A. Francis, MD, MS Stieger Endowed Chair Professor of Ophthalmology Doheny and Stein Eye Institutes Department of Ophthalmology David Geffen School of Medicine University of California, Los Angeles Los Angeles, California
	Jonathan Myers, MD Director, Glaucoma Service Wills Eye Hospital Associate Professor of Ophthalmology Sidney Kimmel Medical College Thomas Jefferson University Philadelphia, Pennsylvania
	Joseph F. Panarelli, MD Associate Professor of Ophthalmology Chief, Division of Glaucoma Services Glaucoma Fellowship Director NYU Langone Eye Center New York, New York
	Arsham Sheybani, MD Assistant Professor of Ophthalmology Fellowship Director, Glaucoma and Anterior Segment Surgery Residency Program Director, Ophthalmology Washington University in St Louis St Louis, Missouri

Disclosure Policy Statement

It is the policy of New York Eye and Ear Infirmary of Mount Sinai that the faculty and anyone in a position to control activity content disclose any real or apparent conflicts of interest relating to the topics of the educational activity in which they are participating. They are also required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. New York Eye and Ear Infirmary of Mount Sinai is committed to providing its learners with quality CME activities and related materials that promote improvements in healthcare and not the proprietary interests of a commercial interest and, thus, has established policies and procedures in place that identify and resolve all conflicts of interest prior to the execution or release of its educational activities. Full disclosure of faculty/planners and their commercial relationships, if any, follows.

Disclosures

Ike K. Ahmed, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Aequus BioPharma, Inc; Aerie Pharmaceuticals, Inc; Alcon; Allergan; ArcScan, Inc; Bausch & Lomb Incorporated; Beaver-Visitec International; Camras Vision, Inc; Carl Zeiss Meditec, Inc; CorNeat Vision Ltd; Ellex; ElutiMed; Equinox; Genentech, Inc; Glaukos Corporation; IanTECH; Injectsense, Inc; IRIDEX Corporation; iSTAR; Ivantis Inc; Johnson & Johnson Vision Care, Inc; Kelotec Inc; LayerBio, Inc; Leica Microsystems; MicroOptx; New World Medical, Inc; Omega Ophthalmics; Polyactiva Pty Ltd; Sanoculis Ltd; Santen Inc; ScienceBased Health; Sight Sciences; Strōma Medical Corporation; TrueVision; Vizzario; and W. L. Gore & Associates, Inc; Contracted Research: Aerie Pharmaceuticals, Inc; Alcon; Allergan; Camras Vision, Inc; Glaukos Corporation; Ivantis Inc; Johnson & Johnson Vision Care, Inc; New World Medical, Inc; and Santen Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Alcon; Allergan; Carl Zeiss Meditec, Inc; and Johnson & Johnson Vision Care, Inc.

Sahar Bedrood, MD, PhD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Allergan; and Glaukos Corporation.

Brian A. Francis, MD, MS, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Beaver-Visitec International; Diopsys, Inc; Glaukos Corporation; NeoMedix Corporation; and Valeant; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Bausch & Lomb Incorporated.

Jonathan Myers, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Aerie Pharmaceuticals, Inc; Allergan; Glaukos Corporation; and MicroOptx; Contracted Research: Aerie Pharmaceuticals, Inc; Alcon; Allergan; Bausch & Lomb Incorporated; Diopsys, Inc; Glaukos Corporation; Heidelberg Engineering GmbH; Novartis Pharmaceuticals Corporation; Shire; Sight Sciences; and ZEISS; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Aerie Pharmaceuticals, Inc; Allergan; and IRIDEX Corporation.

Joseph F. Panarelli, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; New World Medical, Inc; and Santen Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Aerie Pharmaceuticals, Inc; Allergan; and Glaukos Corporation.

Arsham Sheybani, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; and Katena Products, Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Glaukos Corporation.

New York Eye and Ear Infirmary of Mount Sinai Peer Review Disclosure

Kateki Vinod, MD, has no relevant commercial relationships to disclose.

Editorial Support Disclosures

Erika Langsfeld, PhD; Cynthia Tornallyay, RD, MBA, CHCP; Kimberly Corbin, CHCP; Barbara Aubel; and Michelle Ong have no relevant commercial relationships to disclose.

Disclosure Attestation

The contributing physicians listed above have attested to the following:

1. that the relationships/affiliations noted will not bias or otherwise influence their involvement in this activity;
2. that practice recommendations given relevant to the companies with whom they have relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and
3. that all reasonable clinical alternatives will be discussed when making practice recommendations.